Mebazaa, Alexandre
Combes, Alain
van Diepen, Sean
Hollinger, Alexa
Katz, Jaon N.
Landoni, Giovanni
Hajjar, Ludhmila Abrahao
Lassus, Johan
Lebreton, Guillaume
Montalescot, Gilles
Park, Jin Joo
Price, Susanna
Sionis, Alessandro
Yannopolos, Demetris
Harjola, Veli-Pekka
Levy, Bruno
Thiele, Holger
Article History
Received: 10 April 2018
Accepted: 5 May 2018
First Online: 16 May 2018
Compliance with ethical standards
:
: AM received lecture fees from Novartis, Orion, and Abbott, research grants from Roche, and consultant fees from Servier and Sanofi. GL received speaker fees from Orion, Abbvie, and Tenax (companies producing or commercializing levosimendan). BL received lecture fees from Pulsion, Baxter, Orion, and Lilly, and consultant fees from Novartis, Orion, and Baxter. Other coauthors have no conflicts to declare.
Free to read: This content has been made available to all.